More on GSK (GSK +0.2%) Q4: CEO Andrew Witty says company is focused on organic growth and has...

|By:, SA News Editor

More on GSK (GSK +0.2%) Q4: CEO Andrew Witty says company is focused on organic growth and has small appetite for acquisitions; GSK expects Phase III data on 14 assets in 2013 & 2014. Witty expects some job losses in Europe due to pressure on prices, and while he declines to provide too many details of impact on headcount of restructuring, he says the R&D and manufacturing overhaul will focus on new processes rather than staff cuts. (PR)